# Linking Oxidative Stress to Placental Dysfunction: The Key Role of Mitochondria in Trophoblast Function

**Authors:** Ioanna Vasilaki, Anastasios Potiris, Efthalia Moustakli, Despoina Mavrogianni, Nikoletta Daponte, Theodoros Karampitsakos, Alexios Kozonis, Konstantinos Louis, Christina Messini, Themos Grigoriadis, Ekaterini Domali, Sofoklis Stavros

PMC · DOI: 10.3390/medsci14010053 · Medical Sciences · 2026-01-21

## TL;DR

This review explores how oxidative stress disrupts mitochondrial function in trophoblast cells, contributing to placental dysfunction and complications like preeclampsia.

## Contribution

The paper systematically reviews how oxidative stress affects mitochondrial pathways in trophoblasts, linking these changes to placental dysfunction.

## Key findings

- Oxidative stress impairs mitochondrial function in trophoblasts, increasing ROS and triggering apoptosis.
- OS disrupts trophoblast proliferation, migration, and angiogenic balance, contributing to placental dysfunction.
- Mitochondrial DNA release and altered mitophagy are linked to reduced cell viability and pregnancy complications.

## Abstract

Oxidative stress (OS) is a critical regulator of placental development; however, its specific effects on trophoblast biology remain incompletely elucidated. This narrative review synthesizes evidence derived from studies using human placental tissues and trophoblast cell models to delineate how excessive reactive oxygen species (ROS) disrupt molecular and cellular pathways essential for normal placentation. The literature search was restricted to human-based and in vitro investigations. Across these studies, OS was consistently shown to impair mitochondrial function in trophoblasts, resulting in increased mitochondrial ROS generation, loss of mitochondrial membrane potential, and activation of apoptotic signaling cascades. These mitochondrial disturbances were associated with reduced trophoblast proliferation, migration, and invasion, as well as dysregulation of angiogenic balance. Furthermore, several studies reported alterations in mitophagy, involvement of redox-sensitive pathways such as CYP1A1 and KLF9, and the extracellular release of mitochondrial DNA, which was linked to reduced cell viability and increased necrotic cell death. Collectively, the available evidence indicates that OS interferes with key trophoblast-dependent developmental processes, providing mechanistic insight into the pathogenesis of placental dysfunction observed in pregnancy complications such as preeclampsia (PE) and intrauterine growth restriction (IUGR). Elucidation of these pathways may inform the development of targeted therapeutic strategies aimed at preserving placental function and improving adverse pregnancy outcomes.

## Linked entities

- **Genes:** CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543], KLF9 (KLF transcription factor 9) [NCBI Gene 687]
- **Diseases:** preeclampsia (MONDO:0005081), intrauterine growth restriction (MONDO:0005030)

## Full-text entities

- **Genes:** NUDT1 (nudix hydrolase 1) [NCBI Gene 4521] {aka MTH1}, SCARB1 (scavenger receptor class B member 1) [NCBI Gene 949] {aka CD36L1, CLA-1, CLA1, HDLCQ6, HDLQTL6, SR-BI}, TFAM (transcription factor A, mitochondrial) [NCBI Gene 7019] {aka MTDPS15, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2}, SREBF2 (sterol regulatory element binding transcription factor 2) [NCBI Gene 6721] {aka SREBP-2, SREBP2, bHLHd2}, PGM5 (phosphoglucomutase 5) [NCBI Gene 5239] {aka PGMRP}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, ABCG1 (ATP binding cassette subfamily G member 1) [NCBI Gene 9619] {aka ABC8, WHITE1}, ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}, PLAU (plasminogen activator, urokinase) [NCBI Gene 5328] {aka ATF, BDPLT5, QPD, UPA, URK, u-PA}, LDLR (low density lipoprotein receptor) [NCBI Gene 3949] {aka LDLCQ2}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, CS (citrate synthase) [NCBI Gene 1431], GCLC (glutamate-cysteine ligase catalytic subunit) [NCBI Gene 2729] {aka CNSHA7, GCL, GCS, GLCL, GLCLC}, IGF2 (insulin like growth factor 2) [NCBI Gene 3481] {aka C11orf43, GRDF, IGF-II, PP9974, SRS3}, SIRT3 (sirtuin 3) [NCBI Gene 23410] {aka SIR2L3}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, DYSF (dysferlin) [NCBI Gene 8291] {aka FER1L1, LGMD2B, LGMDR2, MMD1}, HNRNPD (heterogeneous nuclear ribonucleoprotein D) [NCBI Gene 3184] {aka AUF1, AUF1A, HNRPD, P37, hnRNPD0}, PIGF (phosphatidylinositol glycan anchor biosynthesis class F) [NCBI Gene 5281] {aka OORS}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, SREBF1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 6720] {aka HMD, IFAP2, SREBP1, bHLHd1}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, BNIP3 (BCL2 interacting protein 3) [NCBI Gene 664] {aka HABON, NIP3}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8) [NCBI Gene 4714] {aka ASHI, CI-ASHI, MC1DN32}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, STOX1 (storkhead box 1) [NCBI Gene 219736] {aka C10orf24}, PRDX1 (peroxiredoxin 1) [NCBI Gene 5052] {aka MSP23, NKEF-A, NKEFA, PAG, PAGA, PAGB}, TIMP2 (TIMP metallopeptidase inhibitor 2) [NCBI Gene 7077] {aka CSC-21K, DDC8}, GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551] {aka E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A, RCH04A07}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, SERPINE1 (serpin family E member 1) [NCBI Gene 5054] {aka PAI, PAI-1, PAI1, PLANH1}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, CYP19A1 (cytochrome P450 family 19 subfamily A member 1) [NCBI Gene 1588] {aka ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX}, DNMT1 (DNA methyltransferase 1) [NCBI Gene 1786] {aka ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT}, ENG (endoglin) [NCBI Gene 2022] {aka END, HHT1, ORW1}, IGF2BP1 (insulin like growth factor 2 mRNA binding protein 1) [NCBI Gene 10642] {aka CRD-BP, CRDBP, IMP-1, IMP1, VICKZ1, ZBP1}, SLC1A5 (solute carrier family 1 member 5) [NCBI Gene 6510] {aka AAAT, ASCT2, ATBO, M7V1, M7VS1, R16}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, NRF1 (nuclear respiratory factor 1) [NCBI Gene 4899] {aka ALPHA-PAL}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1) [NCBI Gene 3157] {aka CMYO28, HMGCS}, ANKRD37 (ankyrin repeat domain 37) [NCBI Gene 353322] {aka Lrp2bp}, FABP5 (fatty acid binding protein 5) [NCBI Gene 2171] {aka E-FABP, EFABP, KFABP, PA-FABP, PAFABP}, HK2 (hexokinase 2) [NCBI Gene 3099] {aka HKII, HXK2}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, DNMT3A (DNA methyltransferase 3 alpha) [NCBI Gene 1788] {aka DNMT3A2, HESJAS, M.HsaIIIA, TBRS}, PPARGC1B (PPARG coactivator 1 beta) [NCBI Gene 133522] {aka ERRL1, PERC, PGC-1(beta), PGC1B}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, EPAS1 (endothelial PAS domain protein 1) [NCBI Gene 2034] {aka ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73}, HSPB8 (heat shock protein family B (small) member 8) [NCBI Gene 26353] {aka CMT2L, DHMN2, E2IG1, H11, HMN2, HMN2A}, MFN1 (mitofusin 1) [NCBI Gene 55669] {aka hfzo1, hfzo2}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, IRS1 (insulin receptor substrate 1) [NCBI Gene 3667] {aka HIRS-1}, ACAT1 (acetyl-CoA acetyltransferase 1) [NCBI Gene 38] {aka ACAT, MAT, T2, THIL}, PARK7 (Parkinsonism associated deglycase) [NCBI Gene 11315] {aka DJ-1, DJ1, GATD2, HEL-S-67p}
- **Diseases:** hypoxic (MESH:D002534), pregnancy loss (MESH:D000022), gestational diabetes (MESH:D016640), preeclamptic (MESH:C538543), H/R (MESH:D000860), metabolic dysfunction (MESH:D008659), Ischemia (MESH:D007511), necrotic (MESH:D009336), proteinuria (MESH:D011507), dyslipidemia (MESH:D050171), hypertensive (MESH:D006973), trophoblast dysfunction (MESH:D014328), ETC complex dysfunction (MESH:D028361), pregnancy complications (MESH:D011248), complications (MESH:D008107), placental insufficiency (MESH:D010927), Inflammation (MESH:D007249), mitochondrial defects (MESH:C565376), injury to (MESH:D014947), IUGR (MESH:D005317), Hyperglycemia (MESH:D006943), reperfusion injury (MESH:D015427), OS (MESH:D000079225), cytotoxicity (MESH:D064420), PE (MESH:D011225), impaired glucose metabolism (MESH:D044882), infection (MESH:D007239), pregnancy failure (MESH:D051437), preterm birth (MESH:D047928), /R (MESH:C580424), diabetic (MESH:D003920), abortion (MESH:D000026), Placental Dysfunction (MESH:D010922), endothelial dysfunction (MESH:D014652), ischemic (MESH:D002545)
- **Chemicals:** cysteine (MESH:D003545), lipid (MESH:D008055), iron (MESH:D007501), LPS (MESH:D008070), sterol (MESH:D013261), alpha-tocopherol (MESH:D024502), ATP (MESH:D000255), GSH (MESH:D005978), 8-OHdG (MESH:D000080242), Cholesterol (MESH:D002784), glucose (MESH:D005947), ROS (MESH:D017382), MEHP (MESH:C016599), blood sugar (MESH:D001786), N-acetylcysteine (MESH:D000111), mercury (MESH:D008628), oxygen (MESH:D010100), superoxide (MESH:D013481), Advanced (-), H2O2 (MESH:D006861), Resolvin D2 (MESH:C545423), methionine (MESH:D008715), GSSG (MESH:D019803), MDA (MESH:D008315), Rapamycin (MESH:D020123), lactate (MESH:D019344), amino acid (MESH:D000596)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Y153H, R364X
- **Cell lines:** HTR-8 — Homo sapiens (Human), Finite cell line (CVCL_D728), HTR-8/SVneo — Homo sapiens (Human), Transformed cell line (CVCL_7162), BeWo — Homo sapiens (Human), Gestational choriocarcinoma, Cancer cell line (CVCL_0044), JEG-3 — Homo sapiens (Human), Gestational choriocarcinoma, Cancer cell line (CVCL_0363)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921961/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12921961/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921961/full.md

---
Source: https://tomesphere.com/paper/PMC12921961